NEDD4L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.334600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.861400E-01
Normal-vs-Stage2
6.652000E-01
Normal-vs-Stage3
1.950010E-01
Normal-vs-Stage4
6.551400E-01
Stage1-vs-Stage2
3.870600E-01
Stage1-vs-Stage3
4.797000E-01
Stage1-vs-Stage4
5.746600E-01
Stage2-vs-Stage3
1.588990E-01
Stage2-vs-Stage4
8.913200E-01
Stage3-vs-Stage4
1.793800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.359800E-01
Normal-vs-AfricanAmerican
7.664400E-01
Normal-vs-Asian
1.723570E-01
Caucasian-vs-AfricanAmerican
1.982950E-01
Caucasian-vs-Asian
6.412400E-02
AfricanAmerican-vs-Asian
1.370420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.046600E-01
Normal-vs-Female
5.261000E-01
Male-vs-Female
5.310800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.517800E-01
Normal-vs-Age(41-60Yrs)
9.974000E-01
Normal-vs-Age(61-80Yrs)
5.306000E-01
Normal-vs-Age(81-100Yrs)
1.647000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.866360E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.016400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.540000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.604100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.029900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.574570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.560400E-01
Normal-vs-Daily Drinker
3.846400E-01
Normal-vs-Weekly Drinker
4.098200E-01
Normal-vs-Occasional Drinker
6.483000E-01
Normal-vs-Social Drinker
9.583000E-01
Non Drinker-vs-Daily Drinker
8.968400E-01
Non Drinker-vs-Weekly Drinker
2.142200E-01
Non Drinker-vs-Occasional Drinker
3.811800E-02
Non Drinker-vs-Social Drinker
2.666400E-01
Daily Drinker-vs-Weekly Drinker
2.389600E-01
Daily Drinker-vs-Occasional Drinker
7.860100E-03
Daily Drinker-vs-Social Drinker
2.662200E-01
Weekly Drinker-vs-Occasional Drinker
3.037300E-04
Weekly Drinker-vs-Social Drinker
8.401500E-02
Occasional Drinker-vs-Social Drinker
6.812000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.835400E-01
Normal-vs-Grade 2
3.164400E-01
Normal-vs-Grade 3
2.070200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.254400E-02
Grade 1-vs-Grade 3
8.062600E-01
Grade 1-vs-Grade 4
2.835400E-01
Grade 2-vs-Grade 3
3.137800E-02
Grade 2-vs-Grade 4
3.164400E-01
Grade 3-vs-Grade 4
2.070200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.905200E-01
Normal-vs-NonDiabetic
6.149000E-01
Diabetic-vs-NonDiabetic
4.364200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.282400E-01
Normal-vs-NoPancreatitis
5.556400E-01
Pancreatitis-vs-NoPancreatitis
6.085200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.515800E-01
Normal-vs-N1
5.928400E-01
N0-vs-N1
8.380400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.995200E-01
Normal-vs-TP53-NonMutant
9.585800E-01
TP53-Mutant-vs-TP53-NonMutant
3.404400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
